Department of Laboratory Medicine
University of Washington
Clinical assay interference and limitations
Fibrinogen [FIBCL]
Methodology: Stago STA clotting assay (Clauss fibrinogen)
When the fibrinogen assay is to be performed on samples collected from patients receiving thrombolytic therapy, the blood samples must be collected with an anticoagulant mixture containing a plasmin inhibitor, such as aprotinin at a final concentration of 0.2 TIU (trypsin inhibitor unit) per ml of blood.
Reference: Stago Quantitative Fibrinogen
assay package insert, 26363 Revised September 1998
Please honor our copyrights
and disclaimer.
Created: February 28, 2002
Copyright ©1999-2002 University of Washington. All rights
reserved.
Update info to: "labmedhelp@u.washington.edu"